Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer

NCT05113199 | Completed

• 1 other identifier: 21-005065
• Study Type: interventional
• Target: 21
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the Virtual Dignity Therapy intervention to palliative care patients with advanced cancer.

Conditions

Advanced Cancer

Keywords

Dignity Therapy

Outcome Measures

Primary Outcomes (2)

• Feasibility Number

  Study feasibility will be measured by the number of participants who enrolled and finished the study.

  2 Years

• Acceptability

  Acceptability, as measured by the 7-item Was it Worth It (WIWI Questionnaire).The questions are answered as either "yes, no, or uncertain," overall perception of quality of life change, overall perception of study experience, one open-ended feedback question, and an option to talk with someone about concerns. Positive responses indicate acceptability. Results are reported as individual items.

  Week 8 (after 3rd intervention session)

Study Arms (1)

Virtual Dignity Therapy

EXPERIMENTAL

Behavioral: Virtual Dignity Therapy

Interventions

Virtual Dignity Therapy BEHAVIORAL

Virtual Dignity Therapy will be facilitated by a registered nurse or medical doctor trained in Dignity Therapy.

Virtual Dignity Therapy

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age ≥18 years
• English fluency
• No diagnosed dementia
• Diagnosis of advanced cancer
• Expected prognosis \> 6 months
• Provide informed consent
• Ability to complete questionnaire(s) by themselves or with assistance

You may not qualify if:

• Other psychological co-morbidities such as untreated schizophrenia, bipolar disease
• Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months
• Active delirium
• Participation in concurrent legacy offerings through the palliative care clinic
• Age ≥18 years
• English fluency
• Provide informed consent
• Supported patient through Dignity Therapy

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Related Links

• Mayo Clinic Clinical Trials

Study Officials

• Deirdre Pachman, MD

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: August 30, 2021
• First Posted: November 9, 2021
• Study Start: November 18, 2021
• Primary Completion: February 17, 2025
• Study Completion: February 17, 2025
• Last Updated: March 3, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)